Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00164515 · ClinicalTrials.gov registry record · Phase 2
Increasing Physical Activity Among Overweight Women With Mobility Disabilities.
A Phase 2 study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 2
- Development phase
- 96
- Enrollment target
NCT00164515: Completed Phase 2 study, sponsored by Centers for Disease Control and Prevention.
NCT00164515 is a Phase 2 study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 96 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (28% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00164515, a Phase 2 study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 96 participants
- Enrollment target
Study Summary
This study aims to increase physical activity among overweight African-American women with mobility limitations.
Primary Outcome
Physical activity was assessed using the Physical Activity and Disability Scale (PADS), the Barriers to Physical Activity and Disbility Scale (B-PADS), (Rimmer et al 2000) and the Mobility Limitation score (Velozo et al 1999).
Interventions
- BEHAVIORAL Personalized exercise programme (PEP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2004-10 |
| Est. Completion | 2007-10 |
| Phase | Phase 2 |
What the finished NCT00164515 record still lists
NCT00164515 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (28% lower).
The record links to 0 conditions, and to 1 intervention - of which Personalized exercise programme (PEP) is the first listed.
NCT00164515 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00164515 about?
NCT00164515 is a clinical study titled "Increasing Physical Activity Among Overweight Women With Mobility Disabilities.". This study aims to increase physical activity among overweight African-American women with mobility limitations.
What is the current status of trial NCT00164515?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 96 participants. The study started on 2004-10. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00164515?
The interventions under investigation include: Personalized exercise programme (PEP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00164515?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00164515's enrollment target sits among peer trials
96 747th of 2000 higher than 1,242 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia